Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tianling Hou

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biomolecules|July 2, 2021
Integrated Multi-Class Classification and Prediction of GPCR Allosteric Modulators by Machine Learning IntelligenceTianling Hou, Yuemin Bian, Terence McGuire, et al.
Frontiers in Pharmacology|August 26, 2021
Comparison of Pinoresinol and its Diglucoside on their ADME Properties and Vasorelaxant Effects on Phenylephrine-Induced ModelYiqiong Pu, Yiqing Cai, Qi Zhang, et al.
Biomaterials|September 17, 2021
Expanding the toolbox of exosome-based modulators of cell functionsQinqin Cheng, Zhefu Dai, Xiaojing Shi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 1, 2020
Macrophage-based nanotherapeutic strategies in ulcerative colitisJiaxin Zhang, Yuge Zhao, Tianling Hou, et al.
Drug Design, Development and Therapy|December 28, 2018
Potential therapeutic effects of <i>Cordyceps cicadae</i> and <i>Paecilomyces cicadae</i> on adenine-induced chronic renal failure in rats and their phytochemical analysisLing Li, Tong Zhang, Chunru Li, et al.
ACS Chemical Neuroscience|September 17, 2020
Binding Characterization of GPCRs-Modulator by Molecular Complex Characterizing System (MCCS)Zhiwei Feng, Tianjian Liang, Siyi Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 18, 2019
Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer ImmunotherapyXiaojing Shi, Qinqin Cheng, Tianling Hou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 16, 2025
Genetically reprogrammed exosomes for immunotherapy of acute myeloid leukemiaLei Zhang, Guoyun Kao, Yuanteng Zhao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 1, 2021
Site-specific antibody-drug conjugates with variable drug-to-antibody-ratios for AML therapyZhefu Dai, Xiao-Nan Zhang, Qinqin Cheng, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biomolecules|July 2, 2021
Integrated Multi-Class Classification and Prediction of GPCR Allosteric Modulators by Machine Learning IntelligenceTianling Hou, Yuemin Bian, Terence McGuire, et al.
Frontiers in Pharmacology|August 26, 2021
Comparison of Pinoresinol and its Diglucoside on their ADME Properties and Vasorelaxant Effects on Phenylephrine-Induced ModelYiqiong Pu, Yiqing Cai, Qi Zhang, et al.
Biomaterials|September 17, 2021
Expanding the toolbox of exosome-based modulators of cell functionsQinqin Cheng, Zhefu Dai, Xiaojing Shi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 1, 2020
Macrophage-based nanotherapeutic strategies in ulcerative colitisJiaxin Zhang, Yuge Zhao, Tianling Hou, et al.
Drug Design, Development and Therapy|December 28, 2018
Potential therapeutic effects of <i>Cordyceps cicadae</i> and <i>Paecilomyces cicadae</i> on adenine-induced chronic renal failure in rats and their phytochemical analysisLing Li, Tong Zhang, Chunru Li, et al.
ACS Chemical Neuroscience|September 17, 2020
Binding Characterization of GPCRs-Modulator by Molecular Complex Characterizing System (MCCS)Zhiwei Feng, Tianjian Liang, Siyi Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 18, 2019
Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer ImmunotherapyXiaojing Shi, Qinqin Cheng, Tianling Hou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 16, 2025
Genetically reprogrammed exosomes for immunotherapy of acute myeloid leukemiaLei Zhang, Guoyun Kao, Yuanteng Zhao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 1, 2021
Site-specific antibody-drug conjugates with variable drug-to-antibody-ratios for AML therapyZhefu Dai, Xiao-Nan Zhang, Qinqin Cheng, et al.
Pageof 1